High-Bleeding Risk and STEMI Patients: Aspirin or Clopidogrel Beyond 1 Month?
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at the Cleveland Clinic Foundation and Interventional Cardiologist at the Cleveland Clinic Heart, Vascular and Thoracic Institute, shared a post on X:
“Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment Elevation:
Do you think there will be a slow decline of aspirin use?”
Title: Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment Elevation
Authors: Yuki Obayashi, Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, Ko Yamamoto, Ryusuke Nishikawa, Tomoya Kimura, Kenji Ando, Satoru Suwa, Tsuyoshi Isawa, Hiroyuki Takenaka, Tetsuya Ishikawa, Hideo Tokuyama, Hiroki Sakamoto, Takanari Fujita, Mamoru Nanasato, Hideki Okayama, Tenjin Nishikura, Hidekuni Kirigaya, Koji Nishida, Koh Ono, Takeshi Kimura
Read the full article here.
Find more on Hemostasis Today.
-
Feb 3, 2026, 17:50Allen Seylani: A Small RNA With a Big Grip on Cholesterol and Heart Disease
-
Feb 3, 2026, 17:39Breaking News from WHO Executive Board Session in Geneva – WFH
-
Feb 3, 2026, 17:26Francesco Lo Monaco: When Calcium Goes to the Wrong Place – Vitamin K and the Mechanisms of Vascular Calcification
-
Feb 3, 2026, 17:18Khalid Ahmed: The HALO Study to Understand Quality of Life After Childhood Hematological Disorders
-
Feb 3, 2026, 17:09Mahesan Subramaniam: The Impact of Chronic Financial Stress and Instability on Cardiovascular Health
-
Feb 3, 2026, 17:01Sunisha A: Deep Vein Thrombosis – A Silent but Serious Threat
-
Feb 3, 2026, 16:56Vicklen Pesiwarissa: Upper Extremity Deep Vein Thrombosis as a Cause of Pulmonary Embolism
-
Feb 3, 2026, 16:52Hope, Independence and Dignity for People with Bleeding Disorders Through the WFH Humanitarian Aid Program
-
Feb 3, 2026, 16:34Join the EHC Round Table on Extremely Rare Bleeding Disorders